| Literature DB >> 35935558 |
Ying Wang1, Menghan Chen1, Peijun Chen2, Jiahui Tong2, Ying Zhang3, Gaoyi Yang3.
Abstract
Background: Currently, there is no evidence-based medical evidence for the diagnosis of lymph node metastasis (LNM) of thyroid cancer (TC) by ultrasound combined with computed tomography (US + CT), and the results of various studies on its diagnostic efficacy are inconsistent. Therefore, the diagnosis of cervical LNM by US + CT is controversial at present. The aims of the present systematic review and meta-analysis were to evaluate the diagnostic performance of US + CT in parallel for diagnosing cervical LNM in patients with TC.Entities:
Keywords: Metastatic lymph node; computed tomography (CT); thyroid cancer (TC); ultrasound (US)
Year: 2022 PMID: 35935558 PMCID: PMC9346219 DOI: 10.21037/gs-22-347
Source DB: PubMed Journal: Gland Surg ISSN: 2227-684X
Figure 1Flowchart demonstrating the process of selecting eligible studies in the meta-analysis. US, ultrasound; CT, computed tomography.
Characteristics of the included studies
| First author | Year | Country | Age (years), mean ± SD | Patients (n) | C | L | Timing of imaging | Histologic type | Study design | CT equipment | US equipment | CT technology | Suspicious CT features | US technology | Suspicious US features | Patient enrollment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ying Liu | 2021 | China | 40.5±9.3 | 600 | 600 | NA | Pre | PTC | R | Philips | GE/Siemens | Contrast enhanced | Enhancement, heterogeneous enhancement, calcification, or cystic or necrotic change | Conventional | Focal or diffuse hyper-echogenicity, calcification, cystic change, abnormal vascular pattern, round shape | NA |
| So Yeon Yang | 2020 | Korea | 45±31 | 453 | 453 | NA | Pre | PTC | R | Siemens | Philips | Contrast enhanced | Strong enhancement without hilar vessel enhancement, heterogeneous enhancement, calcification, or cystic or necrotic change | Conventional | Focal or diffuse hyper-echogenicity, microcalcification, cystic change, abnormal vascular pattern, round shape | Consecutive |
| Younghen Lee | 2018 | Korea | 47.1±12.3 | 351 | 531 | 263 | Pre | TC | P | NA | NA | Contrast enhanced | Calcification, cystic change, strong enhancement without hilar vessel enhancement, heterogeneous enhancement | Conventional | Calcification, cystic change, hyper-echogenicity, peripheral or chaotic color Doppler pattern | Consecutive |
| Qiaoqiao Wei | 2018 | China | NA | 69 | NA | NA | Pre | PTC | R | Siemens | Siemens | Contrast enhanced | NA | Conventional | Local or diffuse high-level echo, small or coarse calcification, cystic degeneration, and sub-round shape | Random |
| Seo Ki Kim | 2017 | Korea | NA | 3,668 | 6,577 | NA | Pre | PTC | R | NA | NA | Contrast enhanced | NA | NA | NA | NA |
| Dae Kwon Na | 2015 | Korea | 48.5±25.5 | 176 | 176 | 176 | Pre | TC | R | GE | GE | Contrast enhanced | Strong enhancement without hilar vessel enhancement, heterogeneous enhancement, calcification, or cystic or necrotic change | High frequency | Irregular cystic change, microcalcification, focal or diffuse hyper-echogenicity, round shape, and loss of fatty echogenic hilum | NA |
| Ganxun Wu | 2014 | China | 44±32 | 115 | 110 | 141 | Pre | PTC | R | NA | NA | Contrast enhanced | Calcification, heterogeneity, cystic change, enhancement | Conventional | Calcification, heterogeneity, cystic change, enhancement, round shape, abnormal vascular pattern | NA |
| DW Lee | 2013 | Korea | 48.5±33.5 | 252 | 262 | 148 | Pre | PTC | R | NA | NA | NA | Enhancement, heterogeneity, calcification, cystic change, round shape (did not apply size criteria for lymph node metastases at level VI) | NA | Enhancement, heterogeneity, calcification, cystic change, round shape (did not apply size criteria for lymph node metastases at level VI) | NA |
| Jung Hyun Yoon | 2011 | Korea | 49±34 | 113 | NA | 122 | Pre | PTC | R | Siemens | Philips | Contrast enhanced | Calcification, central necrosis or cystic change, heterogeneous cortical enhancement | Conventional | Hyper-echogenicity, loss of fatty hilum, cystic change, calcification, round shape, abnormal vascular pattern | Consecutive |
| Ji Soo Choi | 2009 | Korea | 47±27 | 299 | 299 | 53 | Pre | PTC | R | Siemens | Philips | Contrast enhanced | Calcification, cystic or necrotic change, heterogeneous enhancement, strong enhancement without hilar vessel enhancement | Conventional | Focal or diffuse hyper-echogenicity, microcalcification, cystic change, and abnormal vascular pattern | NA |
| Eunhee Kim | 2008 | Korea | 47±31 | 165 | 133 | 144 | Pre | PTC | R | GE/Siemens/Philips | Philips | Contrast enhanced | Strong enhancement without hilar vessel enhancement, heterogeneous enhancement, calcification, or cystic or necrotic change | Conventional | Focal or diffuse hyper-echogenicity, calcification, cystic change, abnormal vascular pattern, or a round shape | Consecutive |
C, central cervical lymph node metastasis; CT, computed tomography; L, lateral cervical lymph node metastasis; NA, not available; P, prospective; Pre, preoperative; PTC, papillary thyroid cancer; R, retrospective; TC, thyroid cancer; US, ultrasound.
Figure 2Quality assessment of the studies selected for the meta-analysis (Quality Assessment of Diagnostic Accuracy Studies-2).
Figure 3Forest plots of the sensitivity and specificity of ultrasound + computed tomography for diagnosing cervical lymph node metastases. Horizontal lines indicate 95% CI of the individual studies. (A) Central cervical lymph node; (B) lateral cervical lymph node; (C) whole cervical lymph node. CI, confidence interval.
Figure 4Receiver-operating characteristic curve of the diagnostic performance of ultrasound + computed tomography for the diagnosis of cervical lymph node metastases. (A) Central cervical lymph node; (B) lateral cervical lymph node; (C) whole cervical lymph node. SENS, sensitivity; SPEC, specificity; SROC, summary receiver operating characteristic; AUC, area under the curve.
Figure 5Deeks’ funnel plot for the evaluation of publication bias. (A) central cervical lymph node, (B) lateral cervical lymph node, and (C) whole cervical lymph node. ESS, explained sum of squares.
Meta-regression analysis that could influence the diagnosis of cervical metastatic lymph nodes in patients with thyroid cancer using ultrasound + computed tomography
| Covariate | Subgroup | Sensitivity | Specificity | P value |
|---|---|---|---|---|
| Central compartments | Total | 0.519 | 0.859 | |
| Consecutive patients | Yes | 0.485 | 0.809 | 0.1900 |
| No | 0.523 | 0.865 | ||
| Study design | R | 0.529 | 0.861 | 0.2663 |
| P | 0.324 | 0.830 | ||
| Country | Korea | 0.483 | 0.866 | 0.7984 |
| China | 0.825 | 0.734 | ||
| Historic type | PTC | 0.532 | 0.861 | 0.2487 |
| TC | 0.337 | 0.835 | ||
| Analysis | Patient based | 0.725 | 0.744 | 0.5404 |
| Node based | 0.471 | 0.871 | ||
| Sample size | ≥200 | 0.521 | 0.860 | 0.6099 |
| <200 | 0.477 | 0.826 | ||
| Lateral compartments | Total | 0.890 | 0.752 | |
| Consecutive patients | Yes | 0.885 | 0.767 | 0.9470 |
| No | 0.900 | 0.735 | ||
| Study design | R | 0.893 | 0.745 | 0.8451 |
| P | 0.881 | 0.827 | ||
| Country | Korea | 0.892 | 0.747 | 0.8760 |
| China | 0.877 | 0.838 | ||
| Historic type | PTC | 0.892 | 0.708 | 0.3677 |
| TC | 0.884 | 0.910 | ||
| Analysis | Patient based | 0.929 | 0.963 | 0.1523 |
| Node based | 0.889 | 0.719 | ||
| Sample size | ≥200 | 0.899 | 0.699 | 0.7181 |
| <200 | 0.876 | 0.870 | ||
| Region | Central | – | – | 0.0075 |
| Lateral | – | – |
P, prospective; PTC, papillary thyroid cancer; R, retrospective; TC, thyroid cancer.